{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:14:39Z","timestamp":1790018079015,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.biopha.2017.06.055","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T10:15:29Z","timestamp":1501841729000},"page":"1158-1164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["MiR-200a expression in CD4+ T cells correlates with the expression of Th17\/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study"],"prefix":"10.1016","volume":"93","author":[{"given":"Xiao-Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.06.055_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5114\/pdia.2014.44003","article-title":"Genetic background of skin barrier dysfunction in the pathogenesis of psoriasis vulgaris","volume":"32","author":"Stawczyk-Macieja","year":"2015","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0625.2012.01459.x","article-title":"Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis","volume":"21","author":"Dombrowski","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings","volume":"133","author":"Martin","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12013-014-0230-z","article-title":"Disruption of circulating CD4+ T-lymphocyte subpopulations in psoriasis patients is ameliorated by narrow-band UVB therapy","volume":"71","author":"Wang","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.biopha.2017.06.055_bib0030","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jbt.20412","article-title":"Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review","volume":"26","author":"Chen","year":"2012","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0045","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","article-title":"Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells","volume":"138","author":"Shimono","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.06.055_bib0050","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/carcin\/bgs235","article-title":"Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity","volume":"33","author":"Zhao","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biopha.2017.06.055_bib0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/bjd.12381","article-title":"Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-alpha therapy","volume":"169","author":"Pivarcsi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0060","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/ijd.13102","article-title":"Increased MicroRNA-1266 levels as a biomarker for disease activity in psoriasis vulgaris","volume":"55","author":"Seifeldin","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","article-title":"Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris","volume":"150","author":"Zhao","year":"2014","journal-title":"Clin. Immunol."},{"issue":"Suppl. 3","key":"10.1016\/j.biopha.2017.06.055_bib0070","doi-asserted-by":"crossref","first-page":"S656","DOI":"10.1245\/s10434-012-2217-6","article-title":"MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma","volume":"19","author":"Kurashige","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0075","doi-asserted-by":"crossref","first-page":"e0124555","DOI":"10.1371\/journal.pone.0124555","article-title":"Nasr-Esfahani MH. miR-141 and miR-200a, revelation of new possible players in modulation of Th17\/Treg differentiation and pathogenesis of multiple sclerosis","volume":"10","author":"Naghavian","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.06.055_bib0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2147\/TCRM.S2740","article-title":"Moderate and severe plaque psoriasis: cost-of-illness study in Italy","volume":"4","author":"Colombo","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.biopha.2017.06.055_bib0085","series-title":"Andrews' Diseases of the Skin: Clinical Dermatology[M]","author":"James","year":"2015"},{"key":"10.1016\/j.biopha.2017.06.055_bib0090","first-page":"1","article-title":"MicroRNA history: discovery, recent applications, and next frontiers","volume":"717","author":"Almeida","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2017.06.055_bib0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-4632.2011.05154.x","article-title":"The roles of cells and cytokines in the pathogenesis of psoriasis","volume":"51","author":"Coimbra","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0105","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1365-2133.2011.10497.x","article-title":"microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris","volume":"165","author":"Ichihara","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.06.055_bib0115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.1202695","article-title":"MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine\/threonine kinase 40","volume":"190","author":"Xu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0625.2012.01462.x","article-title":"MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis","volume":"21","author":"Meisgen","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2010.03.004","article-title":"MicroRNAs and potential target interactions in psoriasis","volume":"58","author":"Zibert","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.biopha.2017.06.055_bib0130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/iub.1412","article-title":"MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation","volume":"67","author":"Guo","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2017.06.055_bib0135","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-12-1959","article-title":"MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer","volume":"19","author":"Yu","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2017.06.055_bib0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","article-title":"Khalil S. Interleukin 17A: toward a new understanding of psoriasis pathogenesis","volume":"71","author":"Lynde","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0145","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.intimp.2010.11.008","article-title":"FOXP3 and RORgammat: transcriptional regulation of Treg and Th17","volume":"11","author":"Chen","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/187152809788681001","article-title":"Migration and function of Th17 cells","volume":"8","author":"Kim","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.biopha.2017.06.055_bib0155","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2017.06.055_bib0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2010.02.021","article-title":"Th17 and regulatory T cells in mediating and restraining inflammation","volume":"140","author":"Littman","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2017.06.055_bib0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217312829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217312829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:26:35Z","timestamp":1766024795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217312829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":33,"alternative-id":["S0753332217312829"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.06.055","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-200a expression in CD4+ T cells correlates with the expression of Th17\/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.06.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}